Trials / Sponsors / Coeptis Therapeutics
Coeptis Therapeutics
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Safety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDS AML, Adult Recurrent, MDS | Phase 1 | 2021-12-15 |
| Completed | Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19 COVID-19 Pneumonia | Phase 1 | 2021-08-01 |